149 related articles for article (PubMed ID: 35546486)
21. Kinesin family member 23, regulated by FOXM1, promotes triple negative breast cancer progression via activating Wnt/β-catenin pathway.
Li Z; Yang HY; Zhang XL; Zhang X; Huang YZ; Dai XY; Shi L; Zhou GR; Wei JF; Ding Q
J Exp Clin Cancer Res; 2022 May; 41(1):168. PubMed ID: 35524313
[TBL] [Abstract][Full Text] [Related]
22. FOXM1 confers to epithelial-mesenchymal transition, stemness and chemoresistance in epithelial ovarian carcinoma cells.
Chiu WT; Huang YF; Tsai HY; Chen CC; Chang CH; Huang SC; Hsu KF; Chou CY
Oncotarget; 2015 Feb; 6(4):2349-65. PubMed ID: 25537512
[TBL] [Abstract][Full Text] [Related]
23. FOXM1/NCAPH activates glycolysis to promote colon adenocarcinoma stemness and 5-FU resistance.
Lei Y; Wang D; Chen W; Tian X; Wei J
Anticancer Drugs; 2023 Sep; 34(8):929-938. PubMed ID: 37260271
[TBL] [Abstract][Full Text] [Related]
24. DNA Methylation Mediated Down-Regulation of miR-370 Regulates Cell Growth through Activation of the Wnt/β-Catenin Signaling Pathway in Human Osteosarcoma Cells.
Zhang W; Duan N; Zhang Q; Song T; Li Z; Zhang C; Chen X; Wang K
Int J Biol Sci; 2017; 13(5):561-573. PubMed ID: 28539830
[TBL] [Abstract][Full Text] [Related]
25. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
[TBL] [Abstract][Full Text] [Related]
26. FOXM1 promotes the warburg effect and pancreatic cancer progression via transactivation of LDHA expression.
Cui J; Shi M; Xie D; Wei D; Jia Z; Zheng S; Gao Y; Huang S; Xie K
Clin Cancer Res; 2014 May; 20(10):2595-606. PubMed ID: 24634381
[TBL] [Abstract][Full Text] [Related]
27. Genetic determinants of FOXM1 overexpression in epithelial ovarian cancer and functional contribution to cell cycle progression.
Barger CJ; Zhang W; Hillman J; Stablewski AB; Higgins MJ; Vanderhyden BC; Odunsi K; Karpf AR
Oncotarget; 2015 Sep; 6(29):27613-27. PubMed ID: 26243836
[TBL] [Abstract][Full Text] [Related]
28. A lignan induces lysosomal dependent degradation of FoxM1 protein to suppress β-catenin nuclear translocation.
Dong GZ; Jeong JH; Lee YI; Han YE; Shin JS; Kim YJ; Jeon R; Kim YH; Park TJ; Kim KI; Ryu JH
Sci Rep; 2017 Apr; 7():45951. PubMed ID: 28378765
[TBL] [Abstract][Full Text] [Related]
29. DLX1 acts as a crucial target of FOXM1 to promote ovarian cancer aggressiveness by enhancing TGF-β/SMAD4 signaling.
Chan DW; Hui WW; Wang JJ; Yung MM; Hui LM; Qin Y; Liang RR; Leung TH; Xu D; Chan KK; Yao KM; Tsang BK; Ngan HY
Oncogene; 2017 Mar; 36(10):1404-1416. PubMed ID: 27593933
[TBL] [Abstract][Full Text] [Related]
30. NOX4-derived ROS-induced overexpression of FOXM1 regulates aerobic glycolysis in glioblastoma.
Su X; Yang Y; Yang Q; Pang B; Sun S; Wang Y; Qiao Q; Guo C; Liu H; Pang Q
BMC Cancer; 2021 Nov; 21(1):1181. PubMed ID: 34740322
[TBL] [Abstract][Full Text] [Related]
31. FOXM1 is a downstream target of LPA and YAP oncogenic signaling pathways in high grade serous ovarian cancer.
Fan Q; Cai Q; Xu Y
Oncotarget; 2015 Sep; 6(29):27688-99. PubMed ID: 26299613
[TBL] [Abstract][Full Text] [Related]
32. Cyclin F and KIF20A, FOXM1 target genes, increase proliferation and invasion of ovarian cancer cells.
Li Y; Guo H; Wang Z; Bu H; Wang S; Wang H; Fang H; Liu Z; Kong B
Exp Cell Res; 2020 Oct; 395(2):112212. PubMed ID: 32771525
[TBL] [Abstract][Full Text] [Related]
33. TRIM24 aggravates the progression of ovarian cancer through negatively regulating FOXM1 level.
Zhou HE; Pan SS; Han H
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10647-10656. PubMed ID: 31858531
[TBL] [Abstract][Full Text] [Related]
34. MFAP2, upregulated by m1A methylation, promotes colorectal cancer invasiveness via CLK3.
Xue M; Mi S; Zhang Z; Wang H; Chen W; Wei W; Lou G
Cancer Med; 2023 Apr; 12(7):8403-8414. PubMed ID: 36583532
[TBL] [Abstract][Full Text] [Related]
35. FOXM1 regulates glycolysis and energy production in multiple myeloma.
Cheng Y; Sun F; Thornton K; Jing X; Dong J; Yun G; Pisano M; Zhan F; Kim SH; Katzenellenbogen JA; Katzenellenbogen BS; Hari P; Janz S
Oncogene; 2022 Aug; 41(32):3899-3911. PubMed ID: 35794249
[TBL] [Abstract][Full Text] [Related]
36. WHSC1 promotes wnt/β-catenin signaling in a FoxM1-dependent manner facilitating proliferation, invasion and epithelial-mesenchymal transition in breast cancer.
Zhang J; Lu J; Chen Y; Li H; Lin L
J Recept Signal Transduct Res; 2020 Oct; 40(5):410-418. PubMed ID: 32314642
[No Abstract] [Full Text] [Related]
37. A lignan from Alnus japonica inhibits glioblastoma tumorspheres by suppression of FOXM1.
Shim JK; Lim SH; Jeong JH; Choi RJ; Oh Y; Park J; Choi S; Hong J; Kim SJ; Moon JH; Kim EH; Teo WY; Park BJ; Chang JH; Ryu JH; Kang SG
Sci Rep; 2022 Aug; 12(1):13990. PubMed ID: 35978012
[TBL] [Abstract][Full Text] [Related]
38. Circ-FOXM1 contributes to cell proliferation, invasion, and glycolysis and represses apoptosis in melanoma by regulating miR-143-3p/FLOT2 axis.
Tian S; Han G; Lu L; Meng X
World J Surg Oncol; 2020 Mar; 18(1):56. PubMed ID: 32183822
[TBL] [Abstract][Full Text] [Related]
39. FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells.
Hamurcu Z; Ashour A; Kahraman N; Ozpolat B
Oncotarget; 2016 Mar; 7(13):16619-35. PubMed ID: 26918606
[TBL] [Abstract][Full Text] [Related]
40. Peritoneal Spread of Ovarian Cancer Harbors Therapeutic Vulnerabilities Regulated by FOXM1 and EGFR/ERBB2 Signaling.
Parashar D; Nair B; Geethadevi A; George J; Nair A; Tsaih SW; Kadamberi IP; Gopinadhan Nair GK; Lu Y; Ramchandran R; Uyar DS; Rader JS; Ram PT; Mills GB; Pradeep S; Chaluvally-Raghavan P
Cancer Res; 2020 Dec; 80(24):5554-5568. PubMed ID: 33087324
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]